La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Lippo Bilan de santé

Santé financière contrôle des critères 1/6

Lippo possède un total de capitaux propres de HK$12.9B et une dette totale de HK$1.6B, ce qui porte son ratio d'endettement à 12.7%. Son actif total et son passif total sont HK$15.1B et de HK$2.2B.

Informations clés

14.7%

Ratio d'endettement

HK$1.74b

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	HK$630.95m
Fonds propres	HK$11.85b
Total du passif	HK$2.28b
Total des actifs	HK$14.13b

Mises à jour récentes de la santé financière

Recent updates

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

May 30

Is Lippo (HKG:226) A Risky Investment?

Oct 28

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Apr 26

Zooming in on HKG:226's 4.0% Dividend Yield

Mar 22

How Much Does Lippo's (HKG:226) CEO Make?

Feb 15

Lippo's(HKG:226) Share Price Is Down 50% Over The Past Three Years.

Jan 19

Is Lippo (HKG:226) A Risky Investment?

Dec 24

Tread With Caution Around Lippo Limited's (HKG:226) 3.9% Dividend Yield

Nov 28

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 226 ( HK$955.7M ) ne couvrent pas ses passifs à court terme ( HK$1.3B ).

Passif à long terme: Les actifs à court terme de 226 ( HK$1.0B ) ne couvrent pas ses passifs à long terme ( HK$1.4B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 226 ( 6.8% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de 226 est passé de 13.9% à 14.7% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de 226 est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 226 sur sa dette sont bien couverts par l'EBIT.

Lippo Bilan de santé

Santé financière contrôle des critères 1/6

Informations clés

Mises à jour récentes de la santé financière

Is Lippo (HKG:226) A Risky Investment?

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Is Lippo (HKG:226) A Risky Investment?

Recent updates

First half 2024 earnings released: HK$0.89 loss per share (vs HK$0.005 profit in 1H 2023)

Lippo Limited to Report Q2, 2024 Results on Aug 27, 2024

Lippo Limited Announces Chief Executive Officer Changes, Effective from 7 June 2024

We Think Some Shareholders May Hesitate To Increase Lippo Limited's (HKG:226) CEO Compensation

Lippo Limited, Annual General Meeting, Jun 06, 2024

Full year 2023 earnings released: HK$0.07 loss per share (vs HK$0.25 profit in FY 2022)

Lippo Limited to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Is Lippo (HKG:226) A Risky Investment?

First half 2023 earnings released: EPS: HK$0.005 (vs HK$0.21 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.005 (vs HK$0.21 in 1H 2022)

New minor risk - Earnings quality

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lippo Limited to Report First Half, 2023 Results on Aug 30, 2023

Full year 2022 earnings released: EPS: HK$0.25 (vs HK$1.01 in FY 2021)

Less than half of directors are independent

Lippo Limited Announces Change of Independent Non-Executive Director- and Composition of Board Committees

Less than half of directors are independent

First half 2022 earnings released

First half 2022 earnings released: EPS: HK$0.21 (vs HK$0.24 in 1H 2021)

Lippo Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022

Lippo Limited to Report First Half, 2022 Results on Aug 30, 2022

Lippo Limited Approves Final Dividend for the Year Ended December 31, 2022

Upcoming dividend of HK$0.04 per share

Less than half of directors are independent

Lippo Limited, Annual General Meeting, Jun 08, 2022

Full year 2021 earnings released: EPS: HK$1.01 (vs HK$2.19 loss in FY 2020)

Lippo Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 29 June 2022

Lippo Limited to Report Fiscal Year 2021 Final Results on Mar 31, 2022

Upcoming dividend of HK$0.03 per share

Lippo Limited Proposes Final Dividend for the Nine Months Ended 31 December 2020

We Think Lippo (HKG:226) Has A Fair Chunk Of Debt

Zooming in on HKG:226's 4.0% Dividend Yield

Lippo Limited to Report Nine Months, 2021 Results on Mar 30, 2021

How Much Does Lippo's (HKG:226) CEO Make?

Lippo's(HKG:226) Share Price Is Down 50% Over The Past Three Years.

First half 2021 earnings released: HK$1.30 loss per share

New 90-day high: HK$2.48

Is Lippo (HKG:226) A Risky Investment?

First half 2021 earnings released: HK$1.30 loss per share

Tread With Caution Around Lippo Limited's (HKG:226) 3.9% Dividend Yield

Lippo Limited to Report First Half, 2021 Results on Nov 27, 2020

New 90-day low: HK$2.04

New 90-day low: HK$2.06

New 90-day low - HK$2.22

Full year earnings released - HK$0.021 loss per share

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines